123 related articles for article (PubMed ID: 10700592)
1. Neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals.
Santiago M; Matarredona ER; Granero L; Cano J; Machado A
Brain Res; 2000 Mar; 858(1):26-32. PubMed ID: 10700592
[TBL] [Abstract][Full Text] [Related]
2. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
Santiago M; Machado A; Cano J
J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
[TBL] [Abstract][Full Text] [Related]
3. Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis.
Santiago M; Machado A; Cano J
J Neurosci Methods; 2001 Jul; 108(2):181-7. PubMed ID: 11478977
[TBL] [Abstract][Full Text] [Related]
4. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
Santiago M; Granero L; Machado A; Cano J
Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
[TBL] [Abstract][Full Text] [Related]
5. In vivo effect of apomorphine and haloperidol on MPP neurotoxicity.
Espinosa-Oliva AM; de Pablos RM; Santiago M
Pharmacology; 2014; 93(3-4):101-7. PubMed ID: 24556705
[TBL] [Abstract][Full Text] [Related]
6. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J
Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658
[TBL] [Abstract][Full Text] [Related]
7. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
8. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra.
Santiago M; Westerink BH; Rollema H
J Neurochem; 1991 Apr; 56(4):1336-42. PubMed ID: 2002346
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals.
Santiago M; Matarredona ER; Granero L; Cano J; Machado A
J Neurochem; 1997 Feb; 68(2):732-8. PubMed ID: 9003064
[TBL] [Abstract][Full Text] [Related]
11. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites.
De Deurwaerdère P; Bonhomme N; Lucas G; Le Moal M; Spampinato U
J Neurochem; 1996 Jan; 66(1):210-5. PubMed ID: 8522956
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
Santiago M; Machado A; Cano J
Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
[TBL] [Abstract][Full Text] [Related]
13. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U
J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929
[TBL] [Abstract][Full Text] [Related]
14. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
Matarredona ER; Santiago M; Machado A; Cano J
Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
[TBL] [Abstract][Full Text] [Related]
15. Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study.
Adachi YU; Watanabe K; Satoh T; Vizi ES
Br J Anaesth; 2001 Jun; 86(6):837-45. PubMed ID: 11573593
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal iron perfusion releases dopamine: an in-vivo microdialysis study.
Prikhojan A; Brannan T; Yahr MD
J Neural Transm (Vienna); 2002 May; 109(5-6):645-9. PubMed ID: 12111456
[TBL] [Abstract][Full Text] [Related]
17. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study.
Alfonso M; Durán R; Campos F; Perez-Vences D; Faro LR; Arias B
Neurochem Res; 2003 Oct; 28(10):1487-93. PubMed ID: 14570393
[TBL] [Abstract][Full Text] [Related]
19. Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum.
Santiago M; Matarredona ER; Machado A; Cano J
J Neurosci Res; 1998 Jun; 52(5):591-8. PubMed ID: 9632315
[TBL] [Abstract][Full Text] [Related]
20. Differences in dopamine efflux induced by MPP+ and beta-carbolinium in the striatum of conscious rats.
Matsubara K; Idzu T; Kobayashi Y; Gonda T; Okunishi H; Kimura K
Eur J Pharmacol; 1996 Nov; 315(2):145-51. PubMed ID: 8960877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
